The Trump administration has revoked a $44 million dollar grant intended for the Birmingham area to bolster Biotechnology ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

The funding reversal disrupts site plans, lab builds and infrastructure tied to real estate development across seven states.

The grant, which would have benefitted the Birmingham Biotechnology Hub, led by Southern Research, has been cancelled. The ...

Pharma giant Eli Lilly is planning a $5.9 billion investment for a massive pharmaceutical manufacturing facility in McCord ...

UCSF scientists register 171 new scientific inventions in 2024 alone. Nearly 100 UCSF inventions were licensed to biotech firms to begin development in the same year. Image: An early 2012 schematic of ...

Story May 12 - NGM Bio: The biotech is shedding around 75% of staff, pausing development of a phase 2 liver disease asset and halting further investment in discovery and preclinical work.

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

Chicago’s life sciences market is the smallest of any major U.S. market by square footage yet has a vacancy rate of 43.3 ...

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...